Skip to content

Collegium Pharmaceutical

US · COLL #3535 by market cap Listed 2015
24.72 -0.49 -1.94%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Collegium Pharmaceutical

Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Founded
2002
CEO
Mr. Vikram Karnani
Employees
423
Headquarters
Stoughton, Massachusetts, United States of America
Fiscal year end
12-31
Website
collegiumpharma.com

Company profile

Exchange
US
Symbol
COLL
Market-cap rank
#3535
Listing date
2015-05-07
Market cap
768.18M
Float cap
698.96M
Shares out
31.08M
Float shares
28.27M

Sectors & themes

Best Growth Stocks Drug Manufacturers - Specialty & Generic Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Collegium Pharmaceutical discussion 0 comments

Add a comment